Fresenius Medical Care (NYSE:FMS) Sets New 1-Year High - Still a Buy?

Fresenius Medical Care AG (NYSE:FMS - Get Free Report)'s stock price reached a new 52-week high during mid-day trading on Friday . The company traded as high as $26.02 and last traded at $26.03, with a volume of 306930 shares changing hands. The stock had previously closed at $25.02.

Analyst Ratings Changes

Separately, StockNews.com raised Fresenius Medical Care from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, February 5th.

Fresenius Medical Care Price Performance

The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The firm has a 50-day moving average of $24.35 and a 200-day moving average of $23.32. The stock has a market cap of $16.55 billion, a PE ratio of 23.31, a PEG ratio of 0.76 and a beta of 0.85.

Fresenius Medical Care (NYSE:FMS - Get Free Report) last posted its earnings results on Tuesday, May 6th. The company reported $0.44 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.01. The firm had revenue of $5.54 billion during the quarter, compared to analysts' expectations of $4.71 billion. Fresenius Medical Care had a net margin of 3.43% and a return on equity of 6.04%. Research analysts predict that Fresenius Medical Care AG will post 1.51 EPS for the current year.

Institutional Investors Weigh In On Fresenius Medical Care

Several hedge funds have recently bought and sold shares of the business. Wayfinding Financial LLC acquired a new stake in Fresenius Medical Care during the 1st quarter worth approximately $25,000. Spire Wealth Management purchased a new stake in shares of Fresenius Medical Care during the first quarter valued at approximately $27,000. Smartleaf Asset Management LLC boosted its holdings in Fresenius Medical Care by 192.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 1,224 shares of the company's stock worth $28,000 after acquiring an additional 806 shares in the last quarter. Wilmington Savings Fund Society FSB purchased a new position in shares of Fresenius Medical Care during the 3rd quarter worth $38,000. Finally, Russell Investments Group Ltd. grew its stake in shares of Fresenius Medical Care by 234.1% in the 4th quarter. Russell Investments Group Ltd. now owns 3,151 shares of the company's stock worth $71,000 after buying an additional 2,208 shares in the last quarter. 8.37% of the stock is owned by hedge funds and other institutional investors.

Fresenius Medical Care Company Profile

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.